These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31977253)

  • 21. Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.
    Prasad V; Goldstein JA
    Eur J Cancer; 2015 Nov; 51(17):2718-23. PubMed ID: 26321010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report.
    Brown AL; Sok P; Scheurer ME; Rabin KR; Marcotte EL; Hawkins DS; Spector LG; Lupo PJ
    Cancer; 2022 Jul; 128(14):2760-2767. PubMed ID: 35482017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.
    Sedrak MS; Freedman RA; Cohen HJ; Muss HB; Jatoi A; Klepin HD; Wildes TM; Le-Rademacher JG; Kimmick GG; Tew WP; George K; Padam S; Liu J; Wong AR; Lynch A; Djulbegovic B; Mohile SG; Dale W;
    CA Cancer J Clin; 2021 Jan; 71(1):78-92. PubMed ID: 33002206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment patterns in a large international randomized controlled trial of perioperative care in cancer patients.
    Gazendam A; Bozzo A; Schneider P; Giglio V; Wilson D; Ghert M
    Trials; 2021 Mar; 22(1):219. PubMed ID: 33743753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global trends in the distribution of cancer types among patients in oncology phase I trials, 1991-2015.
    Itahashi K; Shimizu T; Koyama T; Kondo S; Fujiwara Y; Yamamoto N
    Invest New Drugs; 2019 Feb; 37(1):166-174. PubMed ID: 30083961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
    Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
    J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
    Unger JM; Cook E; Tai E; Bleyer A
    Am Soc Clin Oncol Educ Book; 2016; 35():185-98. PubMed ID: 27249699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data.
    Rogers JR; Liu C; Hripcsak G; Cheung YK; Weng C
    JAMA Netw Open; 2021 Apr; 4(4):e214732. PubMed ID: 33825838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.
    Ledesma Vicioso N; Lin D; Gomez DR; Yang JT; Lee NY; Rimner A; Yamada Y; Zelefsky MJ; Kalman NS; Rutter CE; Kotecha RR; Mehta MP; Panoff JE; Chuong MD; Salner AL; Ostroff JS; Diamond LC; Mathis NJ; Cahlon O; Pfister DG; Zhang Z; Chino F; Tsai J; Gillespie EF
    JCO Oncol Pract; 2022 May; 18(5):e780-e785. PubMed ID: 35544650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State of the controlled clinical trial enterprise in the United States.
    Krall RL
    Clin Pharmacol Ther; 2011 Feb; 89(2):225-8. PubMed ID: 21191384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov.
    Hill KD; Chiswell K; Califf RM; Pearson G; Li JS
    Am Heart J; 2014 Jun; 167(6):921-9.e2. PubMed ID: 24890544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study.
    Pole JD; Barber R; Bergeron RÉ; Carret AS; Dix D; Kulkarni K; Martineau E; Randall A; Stammers D; Strahlendorf C; Strother DR; Truong TH; Sung L
    BMC Cancer; 2017 Jun; 17(1):402. PubMed ID: 28583094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparities in patient enrollment on glioblastoma clinical trials.
    Liu Y; Wasilewski A; Mohile NA
    CNS Oncol; 2020 Jun; 9(2):CNS59. PubMed ID: 32603616
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcoming Barriers to Clinical Trial Enrollment.
    Nipp RD; Hong K; Paskett ED
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():105-114. PubMed ID: 31099636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of older patients with prostate cancer in Medicare eligible trials.
    Craig BM; Gilbert SM; Herndon JB; Vogel B; Quinn GP
    J Urol; 2010 Sep; 184(3):901-6. PubMed ID: 20643449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the rate and reasons of clinical trial failure in urologic oncology.
    Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A
    Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.